Ironsides Asset Advisors’s Pfizer PFE Stock Holding History

Ironsides Asset Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-22,129	Closed	-$745K	–	104
2018 Q1	$745K	Buy	+22,129	New	+$761K	0.29%	46
2017 Q4	–	Sell	-37,981	Closed	-$1.29M	–	90
2017 Q3	$1.29M	Hold	37,981	–	–	0.53%	30
2017 Q2	$1.21M	Hold	37,981	–	–	0.52%	26
2017 Q1	$1.23M	Sell	37,981 -93,660	-71%	-$2.95M	0.54%	28
2016 Q4	$4.06M	Sell	131,641 -5,145	-4%	-$157K	1.11%	19
2016 Q3	$4.4M	Buy	136,786 +39,189	+40%	+$1.31M	1.19%	16
2016 Q2	$3.26M	Sell	97,597 -61,428	-39%	-$1.96M	1%	21
2016 Q1	$4.47M	Buy	159,025 +41,395	+35%	+$1.18M	1.12%	16
2015 Q4	$3.6M	Buy	117,630 +27,984	+31%	+$880K	0.96%	20
2015 Q3	$2.67M	Buy	89,646 +10,172	+13%	+$326K	0.75%	26
2015 Q2	$2.53M	Sell	79,474 -7,457	-9%	-$243K	0.72%	28
2015 Q1	$2.87M	Sell	86,931 -2,888	-3%	-$91.8K	0.78%	27
2014 Q4	$2.65M	Buy	89,819 +1,307	+1%	+$37.5K	0.73%	29
2014 Q3	$2.48M	Sell	88,512 -3,807	-4%	-$107K	0.72%	28
2014 Q2	$2.6M	Buy	+92,319	New	+$2.63M	0.75%	27

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ironsides Asset Advisors's PFE Position: Q2 2018 in Review

Ironsides Asset Advisors sold out of Pfizer (PFE) in Q2 2018, closing a stake of 22,129 shares — an estimated $745K sold.

Ironsides Asset Advisors first reported a position in PFE in Q2 2014 and held it in 15 quarters. The position peaked at $4.47M in Q1 2016. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Ironsides Asset Advisors reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
Ironsides Asset Advisors sold 22,129 Pfizer shares in Q2 2018, an estimated $745K.
Ironsides Asset Advisors first reported a position in Pfizer in Q2 2014 and held it in 15 quarters.
Ironsides Asset Advisors's Pfizer position peaked at $4.47M in Q1 2016.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Ironsides Asset Advisors's 13F filing for Q2 2018, filed 12 Jul 2018.